Tang Capital Partners LP
10% owner at Rain Oncology Inc.; 10% owner at LA JOLLA PHARMACEUTICAL CO; Other at APVO, and 1 more
- Sold, on record
- $21M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Dec 18, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- Rain Oncology Inc.10% owner
- LA JOLLA PHARMACEUTICAL CO10% owner
- APVOAptevo Therapeutics Inc.Other
- VNDAVanda Pharmaceuticals Inc.10% owner
Sales by reason
0
Routine
3
Plan not stated
1
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- APVO1.8M shares
- LA JOLLA PHARMACEUTICAL CO441,290 shares
- VNDA204,500 shares
- Rain Oncology Inc.173,973 shares
Shares sold, every Form 4 sale on record.
Timeline
- Dec 18, 2023No plan
Sold 4.3% of their holdings
$209k173,973 shares at $1.20
- Dec 1, 2021Plan not stated
Sold 4.4% of their holdings
$1.7M441,290 shares at $3.93
- Nov 23, 2021Unusual
Sold 100% of their holdings
$10.4M921,336 shares at $11.25
- Nov 22, 2021Unusual
Sold 47.7% of their holdings
$6.5M838,664 shares at $7.75
- Jan 14, 2010Plan not stated
Sold 2% of their holdings
$589k54,900 shares at $10.73
- Jan 13, 2010Plan not stated
Sold 5.1% of their holdings
$1.6M149,600 shares at $10.71
6 of 6
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | Feb 2, 2024 | Rain Oncology Inc. | 10% owner | Tendered | 3.9M | 0 | SEC | ||
| Dec 18, 2023 | Dec 18, 2023 | Rain Oncology Inc. | 10% owner | Sold | 173,973 | $1.20 | $209k | 3.9M | SEC |
| Jun 1, 2023 | Feb 14, 2024 | TCR2 THERAPEUTICS INC. | 10% owner | Other | 4.4M | 0 | SEC | ||
| May 25, 2023 | May 30, 2023 | TCR2 THERAPEUTICS INC. | 10% owner | Bought | 50,000 | $1.72 | $86k | 4.4M | SEC |
| May 10, 2023 | May 10, 2023 | TCR2 THERAPEUTICS INC. | 10% owner | Bought | 83,988 | $1.95 | $164k | 4.3M | SEC |
| May 5, 2023 | May 5, 2023 | TCR2 THERAPEUTICS INC. | 10% owner | Bought | 289,577 | $1.89 | $548k | 4.2M | SEC |
| Dec 1, 2021 | Dec 1, 2021 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Sold | 441,290 | $3.93 | $1.7M | 9.6M | SEC |
| Nov 23, 2021 | Nov 26, 2021 | APVO | Other | Sold | 921,336 | $11.25 | $10.4M | 0 | SEC |
| Nov 22, 2021 | Nov 22, 2021 | APVO | 10% owner | Sold | 838,664 | $7.75 | $6.5M | 921,336 | SEC |
| Nov 6, 2020 | Nov 6, 2020 | APVO | 10% owner | Bought | 1.4M | $17.30 | $24.8M | 1.8M | SEC |
| Sep 29, 2020 | Sep 30, 2020 | Odonate Therapeutics, Inc. | 10% owner | Bought | 110,882 | $13.14 | $1.5M | 15.2M | SEC |
| Aug 28, 2020 | Sep 1, 2020 | Odonate Therapeutics, Inc. | 10% owner | Bought | 1.1M | $14.25 | $15M | 15.1M | SEC |
| Jun 4, 2020 | Jun 4, 2020 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 615,129 | $4.91 | $3M | 8.7M | SEC |
| Jan 9, 2019 | Jan 9, 2019 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 1.3M | $5.37 | $7M | 4.9M | SEC |
| Dec 31, 2018 | Dec 31, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 63,700 | $13.11 | $835k | 12.9M | SEC |
| Nov 27, 2018 | Nov 29, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 3,063 | $15.64 | $48k | 12.7M | SEC |
| Nov 26, 2018 | Nov 26, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 16,937 | $15.29 | $259k | 12.7M | SEC |
| Sep 28, 2018 | Oct 1, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 40,000 | $19.16 | $766k | 12.7M | SEC |
| Sep 20, 2018 | Sep 20, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 90,000 | $19.55 | $1.8M | 12.6M | SEC |
| Sep 11, 2018 | Feb 14, 2019 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Gift | 500,000 | 3.6M | SEC | ||
| Mar 29, 2018 | Apr 2, 2018 | HRTX | 10% owner | Bought | 192,308 | $26.00 | $5M | 8.5M | SEC |
| Mar 15, 2018 | Mar 19, 2018 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 508,474 | $29.50 | $15M | 4.1M | SEC |
| Mar 2, 2018 | Mar 2, 2018 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 40,000 | $30.06 | $1.2M | 3.6M | SEC |
| Feb 16, 2018 | Feb 16, 2018 | Odonate Therapeutics, Inc. | 10% owner | Bought | 128,255 | $22.47 | $2.9M | 12.3M | SEC |
| Dec 7, 2017 | Dec 8, 2017 | Odonate Therapeutics, Inc. | 10% owner | Bought | 1.3M | $24.00 | $31M | 12.2M | SEC |
| Mar 23, 2017 | Mar 27, 2017 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 149,254 | $33.50 | $5M | 3.4M | SEC |
| Feb 23, 2017 | Feb 27, 2017 | BGMS | 10% owner | Bought | 134,200 | $4.34 | $582k | 559,900 | SEC |
| Jan 19, 2017 | Jan 23, 2017 | HRTX | 10% owner | Bought | 2.5M | $12.20 | $30M | 8.3M | SEC |
| Sep 13, 2016 | Sep 13, 2016 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 139,035 | $19.82 | $2.8M | 3.2M | SEC |
| Mar 3, 2016 | Mar 3, 2016 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 160,000 | $17.82 | $2.9M | 3M | SEC |
| Aug 21, 2015 | Aug 21, 2015 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 170,000 | $27.11 | $4.6M | 2.8M | SEC |
| Jun 26, 2015 | Jun 30, 2015 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 110,000 | $23.58 | $2.6M | 2.6M | SEC |
| Jun 10, 2015 | Jun 12, 2015 | HRTX | 10% owner | Bought | 121,212 | $24.75 | $3M | 4.9M | SEC |
| Dec 15, 2014 | Dec 15, 2014 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Bought | 232,343 | $12.84 | $3M | 2.1M | SEC |
| Nov 20, 2013 | Nov 22, 2013 | HRTX | 10% owner | Awarded | 17.5M | $0.40 | $7M | 81.7M | SEC |
| Oct 24, 2013 | Oct 28, 2013 | Mirati Therapeutics, Inc. | 10% owner | Bought | 57,143 | $17.50 | $1M | 1.2M | SEC |
| Jan 20, 2011 | Jan 24, 2011 | INTRABIOTICS PHARMACEUTICALS INC /DE | 10% owner | Bought | 212,000 | $26.00 | $5.5M | 3.3M | SEC |
| Nov 15, 2010 | Jan 24, 2011 | INTRABIOTICS PHARMACEUTICALS INC /DE | 10% owner | Gift | 225,000 | 67,052 | SEC | ||
| May 20, 2010 | May 26, 2010 | HRTX | Director, 10% owner | Awarded | 95,891 | 138,841 | SEC | ||
| Jan 14, 2010 | Jan 19, 2010 | VNDA | 10% owner | Sold | 54,900 | $10.73 | $589k | 2.7M | SEC |
| Jan 13, 2010 | Jan 13, 2010 | VNDA | 10% owner | Sold | 149,600 | $10.71 | $1.6M | 2.8M | SEC |
| Dec 4, 2009 | Feb 16, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | 10% owner | Gift | 129,242 | 67,052 | SEC | ||
| May 29, 2009 | Jun 2, 2009 | VNDA | 10% owner | SoldCall Options (obligations to sell) | 5,000 | $3.00 | $15k | 20,000 | SEC |
| May 28, 2009 | May 28, 2009 | VNDA | 10% owner | SoldCall Options (obligations to sell) | 15,000 | $2.62 | $39k | 15,000 | SEC |
| Mar 11, 2009 | Mar 13, 2009 | PENWEST PHARMACEUTICALS CO | 10% owner | Bought | 25,100 | $1.35 | $34k | 6.4M | SEC |
| Mar 5, 2009 | Mar 9, 2009 | PENWEST PHARMACEUTICALS CO | 10% owner | Bought | 85,000 | $1.49 | $127k | 5.7M | SEC |
| Feb 23, 2009 | Feb 25, 2009 | PENWEST PHARMACEUTICALS CO | 10% owner | Bought | 24,140 | $1.42 | $34k | 5.6M | SEC |
| Jan 9, 2009 | Jan 12, 2009 | PENWEST PHARMACEUTICALS CO | 10% owner | Bought | 1M | $1.99 | $2M | 4.8M | SEC |
| Dec 18, 2008 | Dec 22, 2008 | HRTX | 10% owner | Bought | 415,300 | $0.48 | $199k | 7.8M | SEC |
| Nov 20, 2008 | Dec 2, 2008 | VNDA | 10% owner | Bought | 145,000 | $0.73 | $106k | 3.7M | SEC |
Page 1
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Dec 18, 2023 | Rain Oncology Inc. | 10% owner | Form 4 sale | 173,973 | $209k | 4.3% | No plan | SEC |
| Dec 1, 2021 | Dec 1, 2021 | LA JOLLA PHARMACEUTICAL CO | 10% owner | Form 4 sale | 441,290 | $1.7M | 4.4% | Plan not stated | SEC |
| Nov 23, 2021 | Nov 26, 2021 | APVO | Other | Form 4 sale | 921,336 | $10.4M | 100.0% | Unusual | SEC |
| Nov 22, 2021 | Nov 22, 2021 | APVO | 10% owner | Form 4 sale | 838,664 | $6.5M | 47.7% | Unusual | SEC |
| Jan 14, 2010 | Jan 19, 2010 | VNDA | 10% owner | Form 4 sale | 54,900 | $589k | 2.0% | Plan not stated | SEC |
| Jan 13, 2010 | Jan 13, 2010 | VNDA | 10% owner | Form 4 sale | 149,600 | $1.6M | 5.1% | Plan not stated | SEC |